243 related articles for article (PubMed ID: 15549648)
1. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).
Sottile V; Seuwen K; Kneissel M
Calcif Tissue Int; 2004 Oct; 75(4):329-37. PubMed ID: 15549648
[TBL] [Abstract][Full Text] [Related]
2. Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat.
Kurabayashi T; Tomita M; Matsushita H; Honda A; Takakuwa K; Tanaka K
Calcif Tissue Int; 2001 Apr; 68(4):248-54. PubMed ID: 11353953
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice.
Tornvig L; Mosekilde LI; Justesen J; Falk E; Kassem M
Calcif Tissue Int; 2001 Jul; 69(1):46-50. PubMed ID: 11685433
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.
Molinuevo MS; Schurman L; McCarthy AD; Cortizo AM; Tolosa MJ; Gangoiti MV; Arnol V; Sedlinsky C
J Bone Miner Res; 2010 Feb; 25(2):211-21. PubMed ID: 19594306
[TBL] [Abstract][Full Text] [Related]
9. Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow.
Hamrick MW; Della Fera MA; Choi YH; Hartzell D; Pennington C; Baile CA
Cell Tissue Res; 2007 Jan; 327(1):133-41. PubMed ID: 17024416
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.
Sorocéanu MA; Miao D; Bai XY; Su H; Goltzman D; Karaplis AC
J Endocrinol; 2004 Oct; 183(1):203-16. PubMed ID: 15525588
[TBL] [Abstract][Full Text] [Related]
11. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
12. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats.
Trivedi R; Kumar S; Kumar A; Siddiqui JA; Swarnkar G; Gupta V; Kendurker A; Dwivedi AK; Romero JR; Chattopadhyay N
Mol Cell Endocrinol; 2008 Jul; 289(1-2):85-93. PubMed ID: 18400372
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone decreases bone mass and bone marrow fat.
Harsløf T; Wamberg L; Møller L; Stødkilde-Jørgensen H; Ringgaard S; Pedersen SB; Langdahl BL
J Clin Endocrinol Metab; 2011 May; 96(5):1541-8. PubMed ID: 21367933
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome.
Tamura N; Kurabayashi T; Nagata H; Matsushita H; Yahata T; Tanaka K
Fertil Steril; 2005 Oct; 84 Suppl 2():1277-84. PubMed ID: 16210021
[TBL] [Abstract][Full Text] [Related]
16. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
17. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
Bonnet N; Laroche N; Vico L; Dolleans E; Benhamou CL; Courteix D
J Pharmacol Exp Ther; 2006 Sep; 318(3):1118-27. PubMed ID: 16740619
[TBL] [Abstract][Full Text] [Related]
18. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
19. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
